Abattis Bioceuticals Corp Stock Analysis
| ATTBF Stock | USD 0.0001 0.00 0.00% |
Abattis Bioceuticals Corp is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Abattis Bioceuticals pink sheet analysis is to determine its intrinsic value, which is an estimate of what Abattis Bioceuticals Corp is worth, separate from its market price. There are two main types of Abattis Bioceuticals' stock analysis: fundamental analysis and technical analysis.
The Abattis Bioceuticals pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Abattis Bioceuticals' ongoing operational relationships across important fundamental and technical indicators.
Abattis |
Abattis Pink Sheet Analysis Notes
The company has price-to-book (P/B) ratio of 0.38. Some equities with similar Price to Book (P/B) outperform the market in the long run. Abattis Bioceuticals Corp recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. The firm had 1:5 split on the 11th of September 2012. Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada. ABATTIS BIOCEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for Abattis Bioceuticals Corp is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Abattis Bioceuticals Corp please contact BBA CA at 808 650 3007 or go to https://www.abattis.com.Abattis Bioceuticals Corp Investment Alerts
| Abattis Bioceuticals generated a negative expected return over the last 90 days | |
| Abattis Bioceuticals has some characteristics of a very speculative penny stock | |
| Abattis Bioceuticals Corp has accumulated 150.86 K in total debt with debt to equity ratio (D/E) of 0.01, which may suggest the company is not taking enough advantage from borrowing. Abattis Bioceuticals Corp has a current ratio of 0.72, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Abattis Bioceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Abattis Bioceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Abattis Bioceuticals Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Abattis to invest in growth at high rates of return. When we think about Abattis Bioceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 356.88 K. Net Loss for the year was (3.04 M) with profit before overhead, payroll, taxes, and interest of 241.34 K. |
Abattis Bioceuticals Thematic Classifications
In addition to having Abattis Bioceuticals pink sheet in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | MarijuanaEntities with exposure to distribution of Marijuana |
Abattis Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 473.03 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abattis Bioceuticals's market, we take the total number of its shares issued and multiply it by Abattis Bioceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Abattis Bioceuticals Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Abattis Bioceuticals Corp Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Abattis Bioceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Abattis Bioceuticals Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Abattis Bioceuticals Outstanding Bonds
Abattis Bioceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Abattis Bioceuticals Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Abattis bonds can be classified according to their maturity, which is the date when Abattis Bioceuticals Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
About Abattis Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Abattis Bioceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Abattis shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Abattis Bioceuticals. By using and applying Abattis Pink Sheet analysis, traders can create a robust methodology for identifying Abattis entry and exit points for their positions.
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada. ABATTIS BIOCEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Abattis Bioceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Complementary Tools for Abattis Pink Sheet analysis
When running Abattis Bioceuticals' price analysis, check to measure Abattis Bioceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abattis Bioceuticals is operating at the current time. Most of Abattis Bioceuticals' value examination focuses on studying past and present price action to predict the probability of Abattis Bioceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abattis Bioceuticals' price. Additionally, you may evaluate how the addition of Abattis Bioceuticals to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |